Cargando…
Disclosure of Investigators' Recruitment Performance in Multicenter Clinical Trials: A Further Step for Research Transparency
Rafael Dal-Ré and colleagues argue that the recruitment targets and performance of all site investigators in multi-centre clinical trials should be disclosed in trial registration sites before a trial starts, and when it ends.
Autores principales: | Dal-Ré, Rafael, Moher, David, Gluud, Christian, Treweek, Shaun, Demotes-Mainard, Jacques, Carné, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246429/ https://www.ncbi.nlm.nih.gov/pubmed/22215987 http://dx.doi.org/10.1371/journal.pmed.1001149 |
Ejemplares similares
-
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
por: Robertson, Jane, et al.
Publicado: (2009) -
Europe Needs a Central, Transparent, and Evidence-Based Approval Process for Behavioural Prevention Interventions
por: Faggiano, Fabrizio, et al.
Publicado: (2014) -
Managing Incidental Genomic Findings in Clinical Trials: Fulfillment of the Principle of Justice
por: Dal-Ré, Rafael, et al.
Publicado: (2014) -
The Global Health System: Strengthening National Health Systems as the Next Step for Global Progress
por: Frenk, Julio
Publicado: (2010) -
Medical journal requirements for clinical trial data sharing: Ripe for improvement
por: Naudet, Florian, et al.
Publicado: (2021)